Bandingkan Harga & Kinerja Mandiri Herindo Adiperkasa Tbk. (MAHA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Mandiri Herindo Adiperkasa Tbk. dan Organon Pharma Indonesia Tbk.: Mandiri Herindo Adiperkasa Tbk. diperdagangkan di Rp145 (kapitalisasi pasar 2,42 T, volume 24 jam 4,28 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Mandiri Herindo Adiperkasa Tbk. jauh lebih besar — sekitar 23,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MAHA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 2,42 T | 104,4 M |
Volume | 4,28 jt | — |
Lot | 42,79 rb | — |
Perputaran | 613,55 jt | — |
Harga Rata-rata | 143,4 | — |
Nilai Transaksi | 613,55 jt | — |
Harga Ekuilibrium Indikatif | 145 | — |
Volume Ekuilibrium Indikatif | 48 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Mandiri Herindo Adiperkasa Tbk.
PT Mandiri Herindo Adiperkasa Tbk. (the Company) is a limited liability company established in the Republic of Indonesia based on Notarial Deed of Julia Rochana Murat, S.H., No. 18 dated January 25, 1994. The Company started commercial activities in 1994.
Selengkapnya di halaman MAHA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
